620 related articles for article (PubMed ID: 23385448)
1. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
2. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
Starke RM; Williams BJ; Jane JA; Sheehan JP
J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
[TBL] [Abstract][Full Text] [Related]
5. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.
Sheehan JP; Starke RM; Mathieu D; Young B; Sneed PK; Chiang VL; Lee JY; Kano H; Park KJ; Niranjan A; Kondziolka D; Barnett GH; Rush S; Golfinos JG; Lunsford LD
J Neurosurg; 2013 Aug; 119(2):446-56. PubMed ID: 23621595
[TBL] [Abstract][Full Text] [Related]
6. Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas.
Lee CC; Kano H; Yang HC; Xu Z; Yen CP; Chung WY; Pan DH; Lunsford LD; Sheehan JP
J Neurosurg; 2014 Mar; 120(3):647-54. PubMed ID: 24405068
[TBL] [Abstract][Full Text] [Related]
7. Cranial nerve dysfunction following Gamma Knife surgery for pituitary adenomas: long-term incidence and risk factors.
Cifarelli CP; Schlesinger DJ; Sheehan JP
J Neurosurg; 2012 Jun; 116(6):1304-10. PubMed ID: 22424563
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas.
Leenstra JL; Tanaka S; Kline RW; Brown PD; Link MJ; Nippoldt TB; Young WF; Pollock BE
Neurosurgery; 2010 Jul; 67(1):27-32; discussion 32-3. PubMed ID: 20559089
[TBL] [Abstract][Full Text] [Related]
9. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery of pituitary adenomas.
Liščák R; Ježková J; Marek J
Neurosurg Clin N Am; 2013 Oct; 24(4):509-19. PubMed ID: 24093569
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Radiosurgery as the Initial Treatment for Patients with Nonfunctioning Pituitary Adenomas.
Hasegawa T; Shintai K; Kato T; Iizuka H
World Neurosurg; 2015 Jun; 83(6):1173-9. PubMed ID: 25700971
[TBL] [Abstract][Full Text] [Related]
12. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function.
Feigl GC; Bonelli CM; Berghold A; Mokry M
J Neurosurg; 2002 Dec; 97(5 Suppl):415-21. PubMed ID: 12507067
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
Leavitt JA; Stafford SL; Link MJ; Pollock BE
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
[TBL] [Abstract][Full Text] [Related]
14. Gamma knife radiosurgery for pituitary adenoma: early results.
Petrovich Z; Yu C; Giannotta SL; Zee CS; Apuzzo ML
Neurosurgery; 2003 Jul; 53(1):51-9; discussion 59-61. PubMed ID: 12823873
[TBL] [Abstract][Full Text] [Related]
15. Gamma Knife surgery for Cushing's disease.
Jagannathan J; Sheehan JP; Pouratian N; Laws ER; Steiner L; Vance ML
J Neurosurg; 2007 Jun; 106(6):980-7. PubMed ID: 17564168
[TBL] [Abstract][Full Text] [Related]
16. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of proton therapy for patients with functional pituitary adenomas.
Wattson DA; Tanguturi SK; Spiegel DY; Niemierko A; Biller BM; Nachtigall LB; Bussière MR; Swearingen B; Chapman PH; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):532-9. PubMed ID: 25194666
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
19. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy.
McClelland S; Higgins PD; Gerbi BJ; Orner JB; Hall WA
Technol Cancer Res Treat; 2007 Jun; 6(3):177-80. PubMed ID: 17535025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
